Precirix

Precirix NV is a private, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing precision radiopharmaceuticals using camelid single-domain antibodies labeled with radioactive isotopes. The company has a broad product pipeline, with one candidate product in Phase I/II clinical trials and two candidate products in late preclinical stages.